Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance.
Nobuya InagakiMasaomi NangakuYasushi SakataKazuyo SasakiKazumi Mori-AnaiTomohisa IwasakiKoume HamadaPublished in: Advances in therapy (2021)
JapicCTI-153048.